Clinical trial
The Bihormonal iLet Bionic Pancreas Feasibility Study
NCT03840278 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Bihormonal iLet Bionic Pancreas Feasibility Study
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 15, 2019
- Completion date
- July 3, 2019
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes mellitus